Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Koup: T Cell VIMC |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2013-02-26 |
| Study Made Public: | 2014-08-05 |
Title
HIV-1 Env-specific CD4+ T Cell Responses in Rhesus Monkeys Induced by Priming Immunization with Different Vectors; Followed by HIV-1 Envelope Protein Boost
Description
CAVD 412 (Study 31) is a non-human primate study to evaluate different protein prime/boost regimens to induce HIV-1 env-specific CD4+ T-cell responses using recombinant vaccine vectors that express HIV-1 Env (1086C).
Sign in to see full information about this study and to download study data.
Products
MF59 1086 Env protein rVSV-1086C Env Plasmid DNA-1086C Env rMVA-1086C EnvIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.